Robert is VP of Artificial Intelligence at GSK, where he explores the ethical and public policy implications of using AI systems in drug discovery and clinical applications. As part of these efforts, Robert leads an academic collaboration with Stanford University, which undertakes independent research aimed at promoting AI-based interventions that are inclusive, empowering, and safe. Prior to Oxford, Robert studied at Cambridge, Harvard, Michigan, and the LSE – where he explored several different fields, including economics, politics, public policy, and philosophy.
kell5834@ox.ac.uk